abstract |
The present invention relates to certain 2- (2,4,5-substituted anilino) pyrimidine compounds and pharmaceutically acceptable salts thereof that may be useful in the treatment or prevention of a medical disease or condition mediated by certain mutated forms of epidermal growth factor receptor (for example the activating mutant L858R. |